Jonathan S. Levin (he/him) is an associate policy researcher at the RAND Corporation. His research examines prescription drug affordability, access to care in public insurance programs, and treatment patterns for individuals with substance use disorders and infectious diseases. Levin's dissertation used econometric and cost-effectiveness methods to estimate how state policies have affected hepatitis C treatment rates. Levin received his Ph.D. from the Johns Hopkins Bloomberg School of Public Health in the Department of Health Policy and Management, an M.P.H. from the Harvard T.H. Chan School of Public Health, and a B.A. from Oberlin College.